by: Bemis, Guy W.; Salituro, Francesco Gerald; Duffy, John Patrick;

Inhibitors of p38

The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.






We claim:

1. A compound of the formula: ##STR38## wherein: each of Q.sub.1 and Q.sub.2 are independently selected from phenyl or pyridyl;

wherein:

Q.sub.1 is substituted with 1 to 4 substituents, independently selected from halo; C.sub.1 -C.sub.3 alkyl; C.sub.1 -C.sub.3 alkyl substituted with NR', OR', CO.sub.2 R' or CONR'.sub.2 ; O--(C.sub.1 -C.sub.3)-alkyl; O--(C.sub.1 -C.sub.3)-alkyl substituted with NR', OR', CO.sub.2 R' or CONR'.sub.2 ; NR'.sub.2 ; OCF.sub.3 ; CF.sub.3 ; NO.sub.2 ; CO.sub.2 R'; CONR'; SR'; SCF.sub.3 ; or CN; and

Q.sub.2 is optionally substituted with up to 4 substituents, independently selected from halo; C.sub.1 -C.sub.3 alkyl; C.sub.1 -C.sub.3 alkyl substituted with NR', OR', CO.sub.2 R' or CONR'.sub.2 ; O--(C.sub.1 -C.sub.3)-alkyl; O--(C.sub.1 -C.sub.3)-alkyl substituted with NR', OR', CO.sub.2 R' or CONR'.sub.2 ; NR'.sub.2 ; OCF.sub.3 ; CF.sub.3 ; NO.sub.2 ; CO.sub.2 R'; CONR'; SR'; SCF.sub.3 ; or CN;

wherein R' is selected from hydrogen, (C.sub.1 -C.sub.3)-alkyl or (C.sub.2 -C.sub.3)-alkenyl or alkynyl;

X is selected from --S--, --O--, --S(O.sub.2)--, --S(O)--, --S(O.sub.2)--N(R)--, --N (R) --S(O.sub.2)--, --N(R)--C(O)O--, --O--C(O)--N(R)--, --C(O)--, --C(O)O--, --O--C(O)--, --C(O)--N(R)--, --N(R) --C(O)--, --N(R)--, or --C(R.sub.2)--;

each R is independently selected from hydrogen, --R.sup.2, --NR.sup.2.sub.2, --OR.sup.2, SR.sup.2, --C(O)--NR.sup.2.sub.2 or --C(O)--OR.sup.2 wherein two adjacent R are optionally bound to one another and, together with each Y to which they are respectively bound, form a 4-8 membered carbocyclic or heterocyclic ring;

R.sup.2 is selected from hydrogen, (C.sub.1 -C.sub.3)-alkyl, O--(C.sub.2 -C.sub.3)-alkyl, (C.sub.1 -C.sub.3)-alkenyl or O--C(C.sub.2 -C.sub.3)-alkenyl, each optionally substituted with W;

W is selected from --N(R').sub.2, --OR', --SR', --S(O)R', --S(O.sub.2)R', C(O)OR', ##STR39## or any 5 to 7-membered heterocyclic ring comprising up to 3 heteroatoms independently selected from N, O or S, wherein said heterocyclic ring is optionally substituted with up to 3 substituents independently selected from halo, C.sub.1 -C.sub.3 alkyl, O--(C.sub.1 -C.sub.3)-alkyl, NR'.sub.2, OCF.sub.3, CF.sub.3, NO.sub.2, CO.sub.2 R', CONR' or CN;

Y is C;

A is N;

n is 1 and

R.sub.1 is selected from hydrogen, (C.sub.1 -C.sub.3)-alkyl, OH, or O--(C.sub.1 -C.sub.3)-alkyl.

2. The compound according to claim 1, wherein Q.sub.1 is selected from phenyl or pyridyl containing 1 to 3 substituents independently selected from chloro, fluoro, bromo, --CH.sub.3, --OCH.sub.3, --OH, --CF.sub.3, --OCF.sub.3, --O(CH.sub.2).sub.2 CH.sub.3 or NH.sub.2, and wherein at least one of said substituents is in the ortho position and said substituents are independently selected from chloro, fluoro, bromo, --CH.sub.3, --OCH.sub.3, --OH, --CF.sub.3, --OCF.sub.3, --O(CH.sub.2).sub.2 CH.sub.3 or NH.sub.2.

3. The compound according to claim 2, wherein Q.sub.1 contains at least two substituents, both of which are in the ortho position.

4. The compound according to claim 2, wherein Q.sub.1 is selected from: ##STR40##

5. The compound according to claim 3, wherein Q.sub.1 is selected from 2,6-difluorophenyl or 2,6-dichlorophenyl.

6. The compound according to claim 1, wherein Q.sub.2 is selected from phenyl or pyridyl and wherein Q.sub.2 optionally contains up to 3 substituents, each of which is independently selected from chloro, fluoro, methyl, --OCH.sub.3, --OH, --NH.sub.2, --CF.sub.3, --OCF.sub.3, --SCH.sub.3, --OCH.sub.3, --C(O)OH and --CH.sub.2 CH.sub.2 OH.

7. The compound according to claim 6, wherein, Q.sub.2 is selected from: or unsubstituted phenyl.

8. The compund according to claim 7, wherein Q.sub.2 is selected from phenyl or 4-fluorophenyl.

9. The compound according to claim 1, wherein X is selected from --S--, --O--, --S(O.sub.2)--, --S(0)--, --NR--, --C(R.sub.2)-- or --C(O)--.

10. The compound according to claim 9, wherein X is S.

11. The compound according to claim 1, wherein each R attached to Y is independently selected from hydrogen or methyl.

12. The compound according to claim 11, having formula: ##STR41## and being selected from the compounds indicated in the table below:

    ______________________________________
    Cmpd# Q.sub.1      Q.sub.2    R.sub.a
                                         R.sub.b
    ______________________________________
    2     4-fluorophenyl
                       phenyl     hydrogen
                                         hydrogen
    3     2,4-dichlorophenyl
                       phenyl     hydrogen
                                         hydrogen
    5     2,4-dichlorophenyl
                       4-methylphenyl
                                  hydrogen
                                         hydrogen
    6     2,6-dichlorophenyl
                       phenyl     hydrogen
                                         hydrogen
    7     2-chlorophenyl
                       phenyl     hydrogen
                                         hydrogen
    8     2-methylphenyl
                       phenyl     hydrogen
                                         hydrogen
    9     3,4-dichlorophenyl
                       phenyl     hydrogen
                                         hydrogen
    10    4-methoxyphenyl
                       phenyl     hydrogen
                                         hydrogen
    11    2-methoxyphenyl
                       phenyl     hydrogen
                                         hydrogen
    12    2,6-dichlorophenyl
                       4-fluorophenyl
                                  hydrogen
                                         hydrogen
    13    2,6-dichlorophenyl
                       phenyl     methyl methyl
    14    2,6-dichlorophenyl
                       4-methylphenyl
                                  hydrogen
                                         hydrogen
    15    2,6-dichlorophenyl
                       3-methlyphenyl
                                  hydrogen
                                         hydrogen
    16    2,6-dichlorophenyl
                       3,4-       hydrogen
                                         hydrogen.
                       dichlorophenyl
    ______________________________________


13. A pharmaceutical composition comprising an amount of a compound according to any one of claims 1 to 12 effective to inhibit p 38, and a pharmaceutcially acceptable carrier.

14. A method of treating or preventing inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, viral disease, or neurodegenerative disease in a pateint, said method comprising administering to said patient a composition according to claim 13.

15. The method according to claim 14, wherein said method is used to treat or prevent an inflammatory disease selected from acute pancreatitis, chronic pancreatitis, asthma, allergies, or adult respiratory distress syndrome.

16. The method according to claim 14, wherein said method is used to treat or prevent an autoimmune disease selected from glomeralonephritis, rheumatoid arthritis, systemic lupus erythematosus, scleroderma, chronic thyroiditis, Graves' disease, autoimmune gastritis, insulin-dependent diabetes mellitus (Type I), autoimmune hemolytic anemia, autoimmune neutropenia, thrombocytopenia, atopic dermatitis, chronic active hepatitis, myasthenia gravis, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, psoriasis, or graft vs. host disease.

17. The method according to claim 14, wherein said method is used to treat or prevent a destructive bone disorders selected from osteoarthritis, osteoporosis or multiple myeloma-related bone disorder.

18. The method according to claim 14, wherein said method is used to treat or prevent a proliferative disease selected from acute myelogenous leukemia, chronic myelogenous leukemia, metastatic melanoma, Kaposi's sarcoma, or multiple myeloma.

19. The method according to claim 14, wherein said method is used to treat or prevent an infectious disease selected from sepsis, septic shock, or Shigellosis.

20. The method according to claim 14, wherein said method is used to treat or prevent a viral disease selected from acute hepatitis infection, HIV infection or CMV retinitis.

21. The method according to claim 14, wherein said method is used to treat or prevent a neurodegenerative disease selected from Alzheimer's disease, Parkinson's disease or cerebral ischemia.

22. A method of treating or preventing ischemia/reperfusion in stroke, or myocardial ischemia, renal ischemia, heart attacks, organ hypoxia or thrombin-induced platelet aggregation in a patient, said method comprising the step of administering to said patient a pharmaceutical composition according to claim 12.

23. A method of inhibiting prostaglandin endoperoxide synthase-2 in a patient, comprising the step of administering to said patient a pharmaceutical composition according to claim 12.

24. The method according to claim 23, wherein said method is used to treat or prevent edema, fever, analgesia or to manage pain.

25. The method according to claim 24, wherein said pain is selected from neuromuscular pain, headache, cancer pain, dental pain or arthritis pain.

logo
Electrophotographic image forming apparatus

Internal combustion engines

Signal reproducing circuit

Article comprising microcavity light sources

Cuvette rail

Cosmetic firming formulation

Tube couplings

Clip

Image recording apparatus

Vacuum assembly for wire unwrapper

Base for roadway marker

Wind energy conversion device

Droppable airborne buoy

Distributed crossbar switch architecture

Infusion instrument

Locking hole punch

Nozzle inner radius inspection system

Programmable operator's console

Memory access optimizing method

Withstand-voltage tire

Extended moment arm anti-spin device

Papermaking belt having reinforcing piles

Shielded cable cutting device

Method of making field emitters

Ophthalmic device for dispensing eyedrops

Cooling device

Endoscopic microsurgical instruments

Diesel engine with mechanical governor

In-situ control system for atomization

N,N'-bis-[(.beta.-hydroxy-.beta.-phenyl)-ethyl]-polymethylenediamines and salts thereof

Composite membranes for fluid separations

Mouse support

Bandanna for pets

Stump cutter

Shoe tongue accessory

Dental post system

Vehicle seat air bag arrangement

Model house

Compressible packages for infusible substances

Structure of angular rate sensor

Steering system for vehicles

Tipping rack for bottle

Wireless telecommunication digital receiver

Optical image defocus correction

Memory protection circuit

Golf course

Combine header grain catch pans

Electrical circuit tester

Polymerization of olefin

Flexible pipe joint system

Recompression staged evaporation system

Card holding device

High-pressure discharge lamp

Compact electric asymmetry brake

Iodine adsorbent

Method for producing resist structures

Drill pipe tong retaining apparatus

Dual curable silicone compositions

Trailer hitch alignment device

Sewing machine

Composite frame member

Automotive air conditioner

Tape tensioning apparatus

Desulfurizing fossil fuels

Statistical weighing

Hammer drills for making boreholes

Radiating device for hyperthermia

High-temperature, non-catalytic, infrared heater

Hydraulically operated engine valve system

Internal combustion engine

Power operated toothbrush

Photoreactive suturing of biological materials

Stretch-wrapped package, process and apparatus

Steam generator arrangement

Energy efficient domestic refrigeration system

Window lifting and lowering apparatus

Suspension mechanism for tracked vehicles

Tape measure

Tubular grafts from purified submucosa

Panel-form loudspeaker

Dipyrromethene metal chelate compounds

Low-temperature fluidity improver

Process for separating dichlorocumene isomer

Device for use in diagnosis

Internal combustion engine

Bottom for planing boats

Locking device

Automobile window shield and covering

Phase shift demodulator

Surveillance system and method

Amino acid sequence pattern matching